Skip to main content
. 2016 Jan 4;29(1):26–34. doi: 10.1097/GCO.0000000000000340

Table 1.

Incidents of tubal precursors in HGSOC

Author % STIC in HGSOCa # STIC # HGSOC SEE-FIM Notes
Leeper et al. [12] 60 3 5 No
Powell et al. [13] 57 4 7 No
Carcangiu et al. [23] 50 3 6 No
Finch et al. [14] 86 6 7 No
Medeiros et al. [18] 100 5 5 Yes
Callahan et al. [24] 100 7 7 No
Kindelberger et al. [20] 48 20 42 Yes
Carlson et al. [25] 40 18 45 Some 47% with SEE-FIM, 35% without SEE-FIM
Hirst et al. [26] 80 4 5 Yes
Jarboe et al. [27] 23 5 22 Yes
Roh et al. [28] 35 30 87 Yes
Maeda et al. [29] 47 7 15 Yes
Przybycin et al. [30] 59 24 41 Yes
Leonhardt et al. [31] 33 3 9 Yes
Manchanda et al. [32] 71 10 14 No
Diniz et al. [33] 71 24 34 Some
Powell et al. [34] 50 5 10 No
Seidman et al. [35] 56 5 9 Some
Tang et al. [36] 19 6 32 Yes
Gao et al. [37] 92 107 116 Yes
Lee et al. [38] 32 6 19 No
Reitsma et al. [39] 75 3 4 Some Cases after 2006 are SEE-FIM
Conner et al. [40] 74 14 19 Yes
Koc et al. [41] 36 9 25 Yes
Mingels et al. [42] 43 23 54 Yes
Sherman et al. [43] 16 4 25 No
Gilks et al. [44] 95 20 21 Yes
Munakata and Yamamoto [45] 22 5 23 Some Only 10% SEE-FIM
Seidman [46] 40 81 202 Some 1991–2007 no SEE-FIM, 2007–2011 half SEE-FIM
Malmberg et al. [47] 61 8 13 No
Mittal et al. [48] 22 7 32 Yes
Zakhour et al. [49] 64 9 14 Some

HGSOC, high-grade serous ovarian carcinoma; SEE-FIM, Sectioning and Extensively Examining the FIMbriated end; STIC, serous tubal intraepithelial carcinoma.

aValues are in %.